---
title: "subsequent_therapies-of-hepatocellular_carcinoma"
date: "2024-06-20"
tags:
  - building
---

> ðŸŒ± created from: [[hepatocellular carcinoma]]

# subsequent_therapies-of-hepatocellular_carcinoma

- first_line:
  - sorafenib
  - lenvatinib
- second_line:
  - regorafenib
  - cabozatinib
- third_line:
  - ramucirumab (for AFP â‰¥400 ng/mL)
- immunotherapy:
  - nivolumab Â± ipilimumab (CheckMate 040)
  - pembrolizumab ([[keynote-240.md|KEYNOTE-240]])
